Christopher Causey Net Worth & Insider Trades

Christopher Causey United Therapeutics Corp

As of November 3, 2022

What is Christopher Causey's Net Worth?

The current estimated net worth of United Therapeutics Corp's Christopher Causey is estimated to be about $19.31M . Christopher Causey owns about 2,835 units of United Therapeutics Corp common stock. In the last 19 years at United Therapeutics Corp, Christopher Causey has sold an estimated value of $29.15M worth.

What is Christopher Causey's Past Insider Trading?

Christopher Causey's largest purchase order was 7,500 units , worth over $1.32M on November 3, 2022. Christopher Causey's largest sale order was 7,500 units , worth over $1.88M on November 3, 2022. In total, Christopher Causey has made about 177 transactions over 19 years of their time at United Therapeutics Corp. Christopher Causey usually trades in June, with the busiest year in 2015.

CHRISTOPHER CAUSEY

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What are United Therapeutics Corp's Past Insider Trades?

United Therapeutics Corp's most recent insider trade came on December 5, 2022 by Martine Rothblatt who sold 16,000 units worth $4.45M . In the last 19 years, insiders at United Therapeutics Corp have sold an estimated value of $1.38B and bought an estimated value of $509.48M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Martine Rothblatt, CHAIRPERSON & CEO,  Paul Mahon, EVP & GENERAL COUNSEL,  and Roger Jeffs .

UNITED THERAPEUTICS Corp Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1